Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antithrombin III Sudbury: an Ala384----Pro mutation with abnormal thrombin-binding activity and thrombotic diathesis.

Thrombosis research - 15 Aug 1990

Pewarchuk W J, Fernandez-Rachubinski F, Rachubinski R A, Blajchman M A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antithrombin III
Share to Base Sequence
Share to Disease Susceptibility
Share to Pedigree

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Polymerase Chain Reaction

Share to Protein Binding

Share to Thrombin

Share to Thrombophlebitis

Source

Identifiers

PMID: 2093312
DOI: 10.1016/0049-3848(90)90061-g

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antithrombin III Sudbury: an Ala384----Pro mutation with abnormal thrombin-binding activity and thrombotic diathesis.PMID 2093312Read ↗

Antithrombin gene mutation 5356-5364*delCTT with type I deficiency and early-onset thrombophilia and a brief review of the antithrombin alpha-helix D molecular pathology.Semantic proximity Read ↗

A novel missense mutation in the antithrombin III gene (Ala387-->Val) causing recurrent venous thrombosis.Semantic proximity Read ↗

A novel missense mutation in the antithrombin III gene (Ser349----Pro) causing recurrent venous thrombosis.Semantic proximity Read ↗

Antithrombin Padua. I: Impaired heparin binding caused by an Arg47 to his (CGT to CAT) substitution.Semantic proximity Read ↗

Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)).Semantic proximity Read ↗

Antithrombin-III-Stockholm: a codon 392 (Gly----Asp) mutation with normal heparin binding and impaired serine protease reactivity.Semantic proximity Read ↗

Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation.Semantic proximity Read ↗

M1761K mutation in the von Willebrand factor A3 domain associated with impaired collagen binding and without platelet dysfunction.Semantic proximity Read ↗

Antithrombin Debrecen (p.Leu205Pro) - Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency.Semantic proximity Read ↗

Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.Semantic proximity Read ↗

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis.Semantic proximity Read ↗

Antithrombin: structure and function.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.